James Schiffer, RPh, associate at Allegaert Berger & Vogel LLC, discusses some tips for pharmacists who are facing a Drug Enforcement Administration audit.

Latest News

Jeannette Y. Wick, RPh, MBA, FASCP
Nasal corticosteroid sprays do not seem to be viable treatments for the common cold.
Rachel Lutz
Losing weight can help decrease the recurrence of atrial fibrillation in overweight patients.
Rachel Lutz
The Advisory Committee on Immunization Practices recently updated the recommended interval between the 13-valeant pneumococcal conjugate vaccine and the 23-valeant pneumococcal polysaccharide vaccine in low-risk elderly patients.
Allison Gilchrist, Associate Editor
Driving under the influence of prescription drugs may be just as dangerous as driving under the influence of alcohol.
Rachel Lutz
Retrospective drug utilization review programs can reduce potentially unsafe concomitant opioid and central nervous system (CNS) medication use.
Meghan Ross, Senior Associate Editor
Chlamydia, gonorrhea, and syphilis are on the rise for the first time since 2006, according to the US Centers for Disease Control and Prevention.
Rachel Lutz
Skipping a flu shot may put patients at greater risk for flu-related pneumonia.
Pharmacy Week in Review: November 24, 2015
This weekly video program highlights the latest in pharmacy news, product news, and more.
Krystle Vermes
Mylan has launched a generic version of Teva Pharmaceuticals’ Adderall in 5 mg, 7.5 mg, 10 mg, 12.5 mg, 20 mg, and 30 mg doses.
Meghan Ross, Senior Associate Editor
The FDA has approved Boehringer Ingelheim’s oral direct thrombin inhibitor dabigatran etexilate mesylate (Pradaxa) for the prophylaxis of deep vein thrombosis and pulmonary embolism in patients who have had hip replacement surgery.

Trending Now

Pharmacist Education

Educated Patient

Colds are caused by a viral infection in the upper airways, sinuses, throat, and nose.
If all individuals with diabetic retinopathy were treated in a timely manner, the incidence of blindness from diabetes could be decreased by 90%.
Approximately 65% of individuals undergoing chemotherapy will experience chemotherapy-induced hair loss, which is usually temporary and completely reversible when therapy ends.
If you are receiving radiation and chemotherapy for cancers of the head and neck, you may experience oral mucositis.
Strategic Alliance Partners
AAP AP Avella Bartell Drugs BASHAS Benzer BiLo Brookshire Brothers Burlington Cardinal Health Cash Wise CCA CobRx Copps Market CostCo CVS Dakota Discount Drug Food-City FoodCity FoodLion Freds Pharmacy Fruth Pharmacy Giant Eagle GNP Haggen Hannaford Bros Harps Harris Teeter Hartig Health Mart Ingles HEB Hi-School Pharmacy HomeTown Hy-Vee Kinney Drug Klingensmith Kmart Kroger LifeCheckDrug Lovelace Pharmacy PMS Marianos Marsh-Main St Mkt Marsh-Main St Mkt Medicine Shoppe Meijer Metro Market NC Mutual Navarro Discount Nucara Pharmacy PDS PharmacaIP Pharmacy First Pick N Save PQA Price Chopper Publix qc Raley Reasors Riteaid Safeway Rochester SavMor Save Mart Schnucks ShopKo ShopRite Smith Spartan Stores Star Discount Stop And Shop Supervalu Target Thrifty White Tops Markets Value Vital Care Walgreens Wal-Mart
Latest Issues